Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

Clinical trial NCT05400577 · WITHDRAWN

Trial details

NCT number: NCT05400577
Sponsor: Fox Chase Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2022-07-13
Primary completion: 2024-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.